Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
13 juil. 2023 08h30 HE
|
Coherus BioSciences, Inc.
First formal distribution agreement for YUSIMRY™, a biosimilar of Humira®, at $995 per carton (two 40 mg/0.8 mL autoinjectors) representing a discount of more than 85% compared to HumiraInnovative...